US 12188948
Metabolite biomarkers for diseases associated with the contact activation system
granted A61PA61P43/00A61P7/10
Quick answer
US patent 12188948 (Metabolite biomarkers for diseases associated with the contact activation system) held by Takeda Pharmaceutical Company Limited expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P43/00, A61P7/10